TUSB yields 3.80% · MRK yields 3.25%● Live data
📍 MRK pulled ahead of the other in Year 1
Combined, TUSB + MRK cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of TUSB + MRK for your $10,000?
TUSB provides segmented exposure to the US fixed income market by actively investing in ultra-short term domestic debt securities with investment grade credit rating. These securities include corporate and government bonds, asset- and mortgage-back securities, preferred stocks, collateralized debt obligations, and other income-producing debt securities. It may also invest a portion in USD-denominated debt of foreign companies. To maintain its ultra-short niche, the fund aims for a dollar-weighted average effective maturity of two years or less. In selecting constituents, the fund uses fundamental and other investment research techniques to assess a securitys value. Since the fund is actively managed, investment decisions are at the discretion of the adviser. TUSB may also utilize derivatives including US treasury future contracts to manage the funds duration and interest risk. The fund seeks a high level of current income.
Full TUSB Calculator →Merck is a Dividend Aristocrat with 14+ consecutive years of increases. Keytruda (pembrolizumab) is the world's best-selling cancer drug and drives exceptional cash generation. The company's oncology and vaccines pipeline provides long-term growth visibility beyond the Keytruda patent cliff in the 2030s.
Full MRK Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.